Evanson Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Evanson Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,700	Closed	-$555K	–	246
2019 Q3	$555K	Hold	20,700	–	–	0.11%	110
2019 Q2	$562K	Hold	20,700	–	–	0.11%	110
2019 Q1	$718K	Buy	20,700 +7,000	+51%	+$202K	0.15%	90
2018 Q4	$267K	Buy	13,700 +3,700	+37%	+$76.1K	0.06%	180
2018 Q3	$266K	Hold	10,000	–	–	0.05%	197
2018 Q2	$378K	Buy	+10,000	New	+$382K	0.08%	165
2018 Q1	–	Sell	-5,000	Closed	-$243K	–	261
2017 Q4	$243K	Hold	5,000	–	–	0.05%	220
2017 Q3	$270K	Buy	+5,000	New	+$294K	0.06%	189

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Evanson Asset Management's PTLA Position: Q4 2019 in Review

Evanson Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2019, closing a stake of 20,700 shares — an estimated $555K sold.

Evanson Asset Management first reported a position in PTLA in Q3 2017 and held it in 8 quarters. The position peaked at $718K in Q1 2019. 224 funds tracked by Wall St. Rank hold PTLA as of Q4 2019.

Evanson Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Evanson Asset Management sold 20,700 Portola Pharmaceuticals, Inc. shares in Q4 2019, an estimated $555K.
Evanson Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Evanson Asset Management's Portola Pharmaceuticals, Inc. position peaked at $718K in Q1 2019.
224 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2019.

Based on Evanson Asset Management's 13F filing for Q4 2019, filed 13 Jan 2020.